Influenza Type A
Influenza Type B
Rapid Flu/COVID-19 Test
Select your testing service:
FSA/HSA accounts accepted
The Rapid Covid-19/Flu A & B test is intended for rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigen from SARS-CoV-2, influenza A and influenza B directly from nasal swab specimens obtained from individuals who are suspected of respiratory viral infection consistent with Covid-19 and Flu A & B. This test provides accurate and reliable results in 15 minutes.
Rapid antigen tests are less sensitive and less specific than PCR tests and therefore, negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with both Covid-19 and Flu A & B. Positive results do not rule out bacterial infection or co-infection with other viruses.
*This test has been granted emergency use authorization (EUA) by the FDA for use at the point-of-care setting care setting that is operating under a CLIA Waiver, Certificate of Compliance or Certificate of Accreditation.
How It Works